Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy.
Ziping WuLei ZhangShuguang XuYanping LinWenjin YinJinglu LuRui ShaXiaonan ShengLiheng ZhouJinsong LuPublished in: Cancer cell international (2019)
Our results showed that high ZEB1 protein expression was a negative predictive marker of pCR and DFS in neoadjuvant therapy in breast cancer patients and in HorR-positive and HER2-overexpressing subgroups.Trial registration NCT, NCT02199418. Registered 24 July 2014-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02199418?term=NCT02199418&rank=1. NCT, NCT 02221999. Registered 21 August 2014-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02221999?term=NCT02221999&rank=1.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- computed tomography
- lymph node
- epithelial mesenchymal transition
- clinical trial
- preterm infants
- magnetic resonance imaging
- long non coding rna
- squamous cell carcinoma
- rectal cancer
- stem cells
- contrast enhanced
- sentinel lymph node
- mesenchymal stem cells
- preterm birth
- real time pcr